CTK7A

CTK7A is a curcumin derivative with anticancer activity by inhibiting the HAT activity of p300 and reducing the autoacetylation of p300, thereby affecting its interaction with HIF-1α. The inhibition of CTK7A leads to decreased HIF-1α accumulation and activity, which can be used for cancer research.

For research use only. We do not sell to patients.

  • CAS No.: 1297262-16-8
  • Formula: C28H23N2NaO6
  • Molecular Weight:506.48
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Epigenetic Reader Domain Isoforms

More

All Histone Acetyltransferase Isoforms

More

All HIF/HIF Prolyl-Hydroxylase Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00